Vanessa M. Naimoli

sanofi-aventis, St. Louis, MO, United States 
Neuroscience, psychopharmacology, latent inhibition, behavioral neuroscience, schizophrenia, MATRICS, neurodevelopment, anxiety, depression, circadian biology, immunity, comparative neuroscience
"Vanessa Naimoli"
Cross-listing: Neurotree


Sign in to add mentor
Alice Powers grad student St. John's University (Neurotree)
Mark D. Black research scientist sanofi-aventis (Neurotree)
Geoffrey Varty research scientist sanofi-aventis (Neurotree)


Sign in to add trainee
Odile Fabre grad student sanofi-aventis (Neurotree)


Sign in to add collaborator
Ina Weiner collaborator sanofi-aventis (Neurotree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Griebel G, Pichat P, Boulay D, et al. (2016) The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia. Scientific Reports. 6: 35320
Naimoli V, Featherstone R, Potestio L, et al. (2015) Compound A, a novel, potent and selective mGluR2 positive allosteric modulator: III. Effects in clinically relevant translational cognition models that could be used as biomarkers F1000research. 4
Rogacki N, Lopez-Grancha M, Naimoli V, et al. (2011) The neurokinin NK2 antagonist, saredutant, ameliorates stress-induced conditions without impairing cognition. Pharmacology, Biochemistry, and Behavior. 98: 405-11
Overstreet DH, Naimoli VM, Griebel G. (2010) Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depression. Pharmacology, Biochemistry, and Behavior. 96: 206-10
See more...